Aquestive Therapeutics (AQST) EBITDA Margin (2017 - 2026)
Aquestive Therapeutics (AQST) posted EBITDA Margin of -172.00% for Q3 2026, down 104.91 percentage points from -67.09% a year earlier and down 126.27 percentage points from the prior quarter.
Aquestive Therapeutics (AQST) EBITDA Margin (2017 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, EBITDA Margin at Aquestive Therapeutics was -118.42%, down 16.39 percentage points year-over-year; for FY2025, it came in at -157.73%, down 124.13 percentage points from FY2024.
- Annual EBITDA Margin shows a five-year change of -77.33 percentage points (FY2020 to FY2025).
- In prior years, Aquestive Therapeutics' EBITDA Margin was -33.60% in FY2024 (-10.30 pp), -23.30% in FY2023 (+59.47 pp), -82.77% in FY2022 (-27.72 pp) and -55.05% in FY2021 (+25.35 pp).
- Quarterly EBITDA Margin has run from a low of -282.07% in Q4 2025 to a high of 14.57% in Q2 2024 over five years.
- On a year-over-year basis, EBITDA Margin increased in two of the last eight quarters, with an average year-over-year change of -52.92 percentage points.
- The strongest year-over-year quarter for EBITDA Margin in the past five years was Q1 2026, with a gain of 176.45 percentage points; the weakest was Q4 2025, with a drop of 191.63 percentage points.
- According to Business Quant data, EBITDA Margin for the three prior quarters was -45.73% (Q2 2026), -12.49% (Q1 2026) and -282.07% (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 54.65% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 40.75% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 42.49% |
| 10 | Aquestive Therapeutics | 445.70 Mn | 24.96 Mn | 3.95 Mn | -172.00% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -172.00% |
| Jun 30, 2026 | -45.73% |
| Mar 31, 2026 | -12.49% |
| Dec 31, 2025 | -282.07% |
| Sep 30, 2025 | -67.09% |
| Jun 30, 2025 | -84.77% |
| Mar 31, 2025 | -188.94% |
| Dec 31, 2024 | -90.44% |
| Sep 30, 2024 | -40.30% |
| Jun 30, 2024 | 14.57% |
| Mar 31, 2024 | -50.42% |
| Dec 31, 2023 | -12.81% |
| Sep 30, 2023 | -16.25% |
| Jun 30, 2023 | -29.61% |
| Mar 31, 2023 | -36.46% |
| Dec 31, 2022 | -96.03% |
| Sep 30, 2022 | -71.61% |
| Jun 30, 2022 | -90.66% |
| Mar 31, 2022 | -73.11% |
| Dec 31, 2021 | -97.59% |
Aquestive Therapeutics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=AQST&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "AQST", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=AQST&period=max&api_key=YOUR_API_KEY");
const data = await res.json();